Pharmafile Logo
Pharmafocus logo
Advanced Search
GSK

NICE says no to lupus treatment

September 30, 2011
Sales and Marketing Benylsta, GSK, Lupus, NICE

NICE has rejected GSK’s new lupus treatment Benlysta in draft guidance.Co-developed with biotech company HGS, the drug has been hailed …

News

Chiltern expands North American Operation with a new office in Illinois

September 30, 2011
Research and Development

 Mr. Barry Simms, Chiltern’s Country Manager, North America, commented, “Chiltern continues to look for opportunities to increase our strategic footprint …

News
Press release

Astellas abandons oral anticoagulant darexaban

September 30, 2011
Research and Development Astellas, Eliquis, Xarelto, darexaban

Astellas Pharma has abandoned the development of its oral direct factor Xa inhibitor darexaban. The Japanese firm blamed both the …

News

NICE refuses to back Sanofi’s Jevtana

September 30, 2011
Sales and Marketing Jevtana, NICE

NICE has not recommended Sanofi’s prostate cancer drug Jevtana due to its high cost and concerns over its safety data. …

News

R&D jobs in emerging markets – leaders wanted

September 29, 2011
Business Services, Research and Development Jobs, careers, pharma jobs

The globalisation of pharmaceutical research and development is creating a wave of job opportunities in emerging markets such as India …

Feature
Merck & Co

Merck pulls out of J&J consumer venture

September 29, 2011
Sales and Marketing J&J, JJ, Merc & Co, OTC

Merck & Co has exited a joint venture with J&J, selling its stake in the J&J/Merck Consumer Pharmaceuticals business to …

News

NICE blames pharma R&D model for spiralling cancer drug costs

September 29, 2011
Research and Development, Sales and Marketing Cancer, NICE, clincial trials

NICE has blamed the pharma industry’s ‘inefficient’ and increasingly costly R&D model for the rising price of cancer drugs. NICE …

News
Novartis

Novartis’ brain tumour drug Votubia launched in UK

September 29, 2011
Sales and Marketing Afinitor, Votubia

Novartis has launched its orphan drug Votubia in the UK for patients with a rare type of brain tumour. Votubia …

News

Commissioning groups want more support and less red tape

September 29, 2011
NHS reforms

Clinical Commissioning Groups are concerned by the amount of bureaucracy they face and feel they don’t have enough support, according …

News

Researchers call for European clinical trial reform

September 28, 2011
Research and Development Euorpe, clinical trials

Medical researchers are calling for regulatory red tape to be snipped away from the legal requirements around clinical trials in …

News
Gardasil

Gardasil better value for money than Cervarix, finds new study

September 28, 2011
Sales and Marketing Cervarix, Gardasil, HPV, cervical cancer

A new report by the Health Protection Agency has found that Gardasil is a more cost-effective vaccine for cervical cancer …

News

Lilly launches ‘open innovation’ drug discovery

September 28, 2011
Research and Development OIDD, TB, lilly

Lilly has launched a new open innovation platform designed to help build its pipeline and to identify new treatments for …

News

SHL to speak at the upcoming Drug Delivery Trends symposium in Korea

September 28, 2011
Manufacturing and Production auto injector, autoinjector, drugy delivery, pharmapack

SHL Marketing Director Steven Kaufman will be speaking at the upcoming Primary Packaging and Drug Delivery Trends for Injectables symposium …

Feature
Press release
Thought Leadership

Cancer costs on an ‘unaffordable trajectory’

September 28, 2011
Sales and Marketing Cancer, healthcare costs

The cost of cancer is rising too fast with new treatments giving uncertain benefits, according to a new study. A …

News

Roche’s Herceptin successor impresses at EMCC

September 27, 2011
Research and Development Herceptin, Roche, TDM-1

Roche’s next-generation breast cancer drug T-DM1 has impressed at the European cancer congress after besting Herceptin in a new study. …

News
Boehringer Ingelheim

Boehringer to create biosimilars division

September 27, 2011
Research and Development Boehringer, biosimilars

Boehringer Ingelheim is to tap into the growing interest in biosimilars with the creation of a division dedicated to that …

News

MTS Medication Technologies appoints Paul O’Hanlon

September 27, 2011
Manufacturing and Production appointments, manufacturing and production

MTS Medication Technologies has appointed Paul O’Hanlon as managing director of its International Division. He has 27 years of experience …

Appointment

Lonza signs regenerative medicine deal with Mesoblast

September 27, 2011
Manufacturing and Production Lonza, Mesoblast, pharma manufacturing news

Lonza has entered into a strategic-level alliance with Mesoblast, a specialist in regenerative medicines, which could see the construction of …

News

SCM Pharma unveils formulation development business

September 27, 2011
Manufacturing and Production SCM Pharma, phamra manufacturing news, pharma manufacturing news

UK contract manufacturer SCM Pharma has set up a formulation development business, thanks to a collaboration with the University of …

News

Pharma manufacturing news in brief

September 26, 2011
Manufacturing and Production pharma manufacturing news

This week’s roundup includes contract manufacturing updates from CMC Biologics, West-Ward and Aenova, plus a Catalent deal in Japan and …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026